학술논문
Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia January 2022 22(1):44-51
Subject
Language
ISSN
2152-2650